Pharmaceuticals markets products for the treatment or prevention of chronic or recurrent illnesses. Goldshield currently markets products which address indications in focus therapeutic areas of Pain & Anaesthesia, Cardiovascular, and Joint & Musculosceletal. The Company distributes its products through retail pharmacies, hospitals and international country distributor network.
This product group serves with a diversified range of therapeutics through broad categories - Specialty Brands needing strong marketing support and lower maintenance costs, Mature Brands requiring limited selling support and Value Generics requiringhigh selling and operational support
Manufacturing and product development is outsourced to reliable established players.
The growth of pharmaceuticals has resulted principally from the Company’s policy of acquiring the UK and Irish rights to marketed products with growth potential with the intention that these would finance further acquisitions and product development programmes. The acquired products have been supplemented, where appropriate, by product line extensions which have led to cost effective and low risk organic growth. |
Business Development
Goldshield aims to continue to grow through the following strategies:
Introducing New products into the Group through:
- Acquisitions (strategic alliances)
- Specialised product development (line extensions)
- In-licensing
Developing Existing products in the Group through:
- Specialised products development (new territories or new markets)
Goldshield is interested in hearing from companies who can offer opportunities in these areas.
Contact us to submit a product opportunity. |
